Andy Hsieh
Stock Analyst at William Blair
(0)
# 4878
Out of 5,218 analysts
15
Total ratings
50.00%
Success rate
-28.99%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Pyxis Oncology | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Nov 21, 2024 | |
Fusion Pharmaceutica... | Downgrades: Market Perform | n/a | n/a | n/a | 2 | Mar 19, 2024 | |
CymaBay Therapeutics | Downgrades: Market Perform | n/a | n/a | n/a | 2 | Feb 12, 2024 | |
RayzeBio | Downgrades: Market Perform | n/a | n/a | n/a | 2 | Dec 26, 2023 | |
Lantheus Holdings | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | May 25, 2021 |